Key result
Supine hypertension affects over 50% of patients with autonomic failure and orthostatic hypotension, yet lacks official treatment guidelines and proven long-term benefits.
Why the study?
Supine hypertension affects over 50% of patients with autonomic failure and orthostatic hypotension, yet official guidelines on its treatment are lacking and long-term benefits have not been proved.
What are the diagnostic and therapeutic management strategies for supine hypertension in patients with autonomic failure?
What are the diagnostic and therapeutic management strategies for supine hypertension in patients with autonomic failure?
This review provides a comprehensive overview of the diagnosis and management of supine hypertension in autonomic failure, an often overlooked condition lacking official treatment guidelines.
Supine hypertension may contribute to organ damage in autonomic failure; leaves open dedicated trials and guidelines.
: Supine hypertension is defined as a blood pressure at least 140 mmHg systolic or at least 90 mmHg diastolic in the supine position; supine hypertension is present in over 50% of patients with autonomic failure and orthostatic hypotension, but it is often overlooked. It may be related to antihypotensive drugs, but its presence in untreated patients suggests a neurogenic origin. Supine hypertension is often asymptomatic although it is associated with multiple organ damage. There are no official guidelines on its treatment and long-term benefits have never been proved. The present review is focused on the management of supine hypertension, including nonpharmacological and pharmacological approach. All the tested drugs have been individually revised, focusing on their hypotensive effect and their ability to act on ancillary targets, such as morning orthostatic tolerance or sodium urine excretion. Moreover, the main pathogenic mechanisms and the correct approach to the diagnosis of supine hypertension have been resumed.
No takes yet. Share an insight, caveat, or question.
Vallelonga et al. (2019) conducted a review in Supine hypertension in autonomic failure. Nonpharmacological and pharmacological management was evaluated. Supine hypertension affects over 50% of patients with autonomic failure and orthostatic hypotension, yet lacks official treatment guidelines and proven long-term benefits.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: